Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma.
Joshkon A, Tabouret E, Traboulsi W, Bachelier R, Simoncini S, Roffino S, Jiguet-Jiglaire C, Badran B, Guillet B, Foucault-Bertaud A, Leroyer AS, Dignat-George F, Chinot O, Fayyad-Kazan H, Bardin N, Blot-Chabaud M.
Joshkon A, et al. Among authors: badran b.
Acta Neuropathol Commun. 2022 Oct 23;10(1):151. doi: 10.1186/s40478-022-01451-3.
Acta Neuropathol Commun. 2022.
PMID: 36274147
Free PMC article.